Scarica l'app Stockscreener
56.85
0.28%
0.16
Dopo l'orario di chiusura:
56.85
Xenon Pharmaceuticals Inc Borsa (XENE) Ultime notizie
XENE SEC FilingsXenon Pharmaceut 10-K, 10-Q, 8-K Forms - Stock Titan
Aberdeen Group plc Increases Stock Position in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Xenon Pharmaceuticals (XENE) climbs 31.7% as epilepsy treatment moves forward - MSN
XENE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
XENE PE Ratio & Valuation, Is XENE Overvalued - Intellectia AI
Xenon Pharmaceuticals Inc.Common Shares (NQ: XENE - The Chronicle-Journal
Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE) - MarketBeat
Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know - AOL.com
Xenon Pharmaceuticals stock soars 20% in 3 months: Here's why - MSN
How Positive Phase 3 Azetukalner Results and Upsized Financing Could Reframe Xenon Pharmaceuticals (XENE) Investors - Sahm
Assenagon Asset Management S.A. Invests $5.34 Million in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price Crosses Above Fifty Day Moving AverageTime to Sell? - marketbeat.com
Assessing Xenon Pharmaceuticals (XENE) Valuation After Positive Phase 3 Results And US$750 Million Capital Raise - Sahm
Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know - The Motley Fool
Xenon Pharmaceuticals (XENE) price target increased by 41.64% to 80.01 - MSN
Wolfe Research initiates coverage of Xenon Pharmaceuticals (XENE) with outperform recommendation - MSN
Crude oil rises around 4%; Xenon Pharmaceuticals shares surge - MSN
(XENE) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Published on: 2026-03-22 04:08:37 - baoquankhu1.vn
Xenon Pharmaceuticals rallies after pivotal data shows major drop in monthly seizures - MSN
Xenon Pharmaceuticals stock faces pipeline scrutiny amid biotech sector volatility - AD HOC NEWS
JPMorgan Chase & Co. Purchases 142,452 Shares of Xenon Pharmaceuticals Inc. $XENE - marketbeat.com
Xenon Pharmaceuticals Shares Jump 20% Over Three Months: The Reasons Explained - Bitget
Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why - The Globe and Mail
Investors Buy High Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - MarketBeat
Xenon Pharmaceuticals (XENE) Is Down 6.7% After $650 Million Follow-On Offering And Phase 3 Epilepsy Win - Yahoo Finance
Assessing Xenon Pharmaceuticals (XENE) Valuation After Positive Phase 3 X TOLE2 Azetukalner Results - simplywall.st
XENE stock up as Azetukalner meets goal in focal onset seizures study - MSN
XENE Technical Analysis & Stock Price Forecast - Intellectia AI
Jain Global LLC Takes Position in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Xenon Pharmaceuticals Inc. $XENE Shares Sold by Granahan Investment Management LLC - MarketBeat
Holocene Advisors LP Acquires 167,078 Shares of Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Cinctive Capital Management LP Takes Position in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Xenon Pharmaceuticals Inc. $XENE Shares Sold by Bamco Inc. NY - MarketBeat
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Rating of "Buy" by Brokerages - marketbeat.com
XENE: Wedbush Adjusts Target Price for Xenon Pharmaceuticals | X - GuruFocus
Xenon Pharmaceuticals (NASDAQ:XENE) Price Target Cut to $63.00 by Analysts at Wedbush - MarketBeat
Wedbush lowers Xenon Pharmaceuticals stock price target to $63 - Investing.com
HighVista Strategies LLC Increases Stock Holdings in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
5 Stocks Making Huge Moves this Week - Insider Monkey
Xenon Pharmaceuticals (XENE) Climbs 31.7% as Epilepsy Treatment Moves Forward - Insider Monkey
Commodore Capital LP Has $108.41 Million Position in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):